Fertility in Norwegian Testicular Cancer Patients
Author Information
Author(s): Fosså S D, Kravdal Ø
Primary Institution: The Norwegian Radium Hospital
Hypothesis
The study explores the relationship between fertility and testicular cancer, including treatment-induced changes over time.
Conclusion
Fertility rates among testicular cancer patients decreased by roughly 30% compared to the normal population, but treatment advancements have improved the ability to father children post-diagnosis.
Supporting Evidence
- Fertility rates among testicular cancer patients decreased by roughly 30% compared to the normal population.
- The introduction of cisplatin chemotherapy and nerve-sparing RPLND improved post-treatment fertility.
- Increasing parity reduces the risk of being diagnosed with seminoma.
Takeaway
This study found that men who had testicular cancer had fewer children than other men, but new treatments helped some of them have kids after their treatment.
Methodology
Data were analyzed using Poisson regression models to compare birth rates among testicular cancer patients with those of other men.
Participant Demographics
Testicular cancer patients born after 1935 and treated before 1991.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website